These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 18520987)

  • 1. Antipsychotic-induced paroxysmal perceptual alteration.
    Praharaj SK; Arora M; Ray P
    Clin Neuropharmacol; 2008; 31(3):184-6. PubMed ID: 18520987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipsychotic-induced paroxysmal perceptual alteration.
    Uchida H; Suzuki T; Watanabe K; Yagi G; Kashima H
    Am J Psychiatry; 2003 Dec; 160(12):2243-4. PubMed ID: 14638603
    [No Abstract]   [Full Text] [Related]  

  • 3. [Paroxysmal perceptual alteration in comparison with hallucination--a review of its clinical reports and discussion of its pathophysiological mechanism in the present day, when second generation antipsychotics are widely used].
    Watanabe K
    Seishin Shinkeigaku Zasshi; 2009; 111(2):127-36. PubMed ID: 19378769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Add-on oral olanzapine worsens hallucinations in schizoaffective disorder.
    Volpe U; Vignapiano A; Gallo O; Fabrazzo M
    BMJ Case Rep; 2014 Oct; 2014():. PubMed ID: 25336551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risperidone-induced paroxysmal perceptual alteration in a child with autism.
    Bozkurt H; Ayaydın H; Adak İ; Zoroğlu SS
    J Child Adolesc Psychopharmacol; 2012 Dec; 22(6):470-1. PubMed ID: 23234592
    [No Abstract]   [Full Text] [Related]  

  • 6. Disturbed glucose metabolism among patients taking olanzapine and typical antipsychotics.
    Dunlop BW; Sternberg M; Phillips LS; Andersen J; Duncan E
    Psychopharmacol Bull; 2003; 37(3):99-117. PubMed ID: 14608243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent episodes of perceptual alteration in patients treated with antipsychotic agents.
    Uchida H; Suzuki T; Tanaka KF; Watanabe K; Yagi G; Kashima H
    J Clin Psychopharmacol; 2003 Oct; 23(5):496-9. PubMed ID: 14520127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long term treatment with olanzapine mixed with the food in male rats induces body fat deposition with no increase in body weight and no thermogenic alteration.
    Minet-Ringuet J; Even PC; Goubern M; Tomé D; de Beaurepaire R
    Appetite; 2006 May; 46(3):254-62. PubMed ID: 16551485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EEG abnormalities associated with antipsychotics: a comparison of quetiapine, olanzapine, haloperidol and healthy subjects.
    Amann BL; Pogarell O; Mergl R; Juckel G; Grunze H; Mulert C; Hegerl U
    Hum Psychopharmacol; 2003 Dec; 18(8):641-6. PubMed ID: 14696024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective database analysis on the effectiveness of typical and atypical antipsychotic drugs in an outpatient clinic setting.
    Akkaya C; Sarandol A; Cangur S; Kirli S
    Hum Psychopharmacol; 2007 Dec; 22(8):515-28. PubMed ID: 17868197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical antipsychotics for the treatment of delirious elders.
    Ozbolt LB; Paniagua MA; Kaiser RM
    J Am Med Dir Assoc; 2008 Jan; 9(1):18-28. PubMed ID: 18187109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol.
    Dossenbach M; Erol A; el Mahfoud Kessaci M; Shaheen MO; Sunbol MM; Boland J; Hodge A; O'Halloran RA; Bitter I;
    J Clin Psychiatry; 2004 Mar; 65(3):312-21. PubMed ID: 15096069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weight gain induced by haloperidol, risperidone and olanzapine after 1 year: findings of a randomized clinical trial in a drug-naïve population.
    Perez-Iglesias R; Crespo-Facorro B; Martinez-Garcia O; Ramirez-Bonilla ML; Alvarez-Jimenez M; Pelayo-Teran JM; Garcia-Unzueta MT; Amado JA; Vazquez-Barquero JL
    Schizophr Res; 2008 Feb; 99(1-3):13-22. PubMed ID: 18053689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia.
    Ascher-Svanum H; Stensland M; Zhao Z; Kinon BJ
    BMC Psychiatry; 2005 Jan; 5():3. PubMed ID: 15649317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olanzapine vs haloperidol for treatment of schizophrenia.
    Glazer WM
    JAMA; 2004 Mar; 291(9):1064-5; author reply 1065-6. PubMed ID: 14996766
    [No Abstract]   [Full Text] [Related]  

  • 16. Methamphetamine psychosis in which tardive dystonia was successfully treated with clonazepam.
    Yamamoto N; Oda T; Inada T
    Psychiatry Clin Neurosci; 2007 Dec; 61(6):691-4. PubMed ID: 18081635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol.
    Keefe RS; Seidman LJ; Christensen BK; Hamer RM; Sharma T; Sitskoorn MM; Lewine RR; Yurgelun-Todd DA; Gur RC; Tohen M; Tollefson GD; Sanger TM; Lieberman JA
    Am J Psychiatry; 2004 Jun; 161(6):985-95. PubMed ID: 15169686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol.
    Saddichha S; Ameen S; Akhtar S
    J Clin Psychopharmacol; 2008 Feb; 28(1):27-31. PubMed ID: 18204337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olanzapine and haloperidol in first episode psychosis: two-year data.
    Green AI; Lieberman JA; Hamer RM; Glick ID; Gur RE; Kahn RS; McEvoy JP; Perkins DO; Rothschild AJ; Sharma T; Tohen MF; Woolson S; Zipursky RB;
    Schizophr Res; 2006 Sep; 86(1-3):234-43. PubMed ID: 16887334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delirium with visual hallucinations induced by low-dose olanzapine.
    Takeuchi N; Makino T; Nishihara M
    Psychogeriatrics; 2022 May; 22(3):415-416. PubMed ID: 35274396
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.